研究業績

論文業績　2009～

2011

  1. 1.Minomo A, Ishima Y, Kragh-Hansen U, Chuang VT, Uchida M, Taguchi K, Watanabe H, Maruyama T, Morioka H, Otagiri M. Biological characteristics of two lysines on human serum albumin in the high-affinity binding of 4Z,15Z-bilirubin-IXα revealed by phage display. FEBS J. 2011 Nov;278(21):4100-11.
  2. 2.Guo J, Jono H, Kugimiya T, Saito S, Maruyama T, Misumi Y, Hoshii Y, Su Y, Shono M, Ueda M, Obayashi K, Otagiri M, Ando Y. Antioxidative effect of albumin on amyloid fibril formation in transthyretin-related amyloidosis. Amyloid. 2011 Jun;18 Suppl 1:12-3. No abstract available.
  3. 3.Ishima Y, Yoshida F, Kragh-Hansen U, Watanabe K, Katayama N, Nakajou K, Akaike T, Kai T, Maruyama T, Otagiri M. Cellular uptake mechanisms and responses to NO transferred from mono- and poly-S-nitrosated human serum albumin. Free Radic Res. 2011 Oct;45(10):1196-206.
  4. 4.Zhang JS, Kadowaki D, Nonoguchi H, Hirata S, Seo H, Imai T, Suenaga A, Giam Chuang VT, Otagiri M. Toxicodynamic evaluation of a cisplatin-chondroitin sulfate complex using a perfused kidney and human proximal tubular cells. Ren Fail. 2011;33(6):609-14.
  5. 5.Furukawa M, Tanaka R, Chuang VT, Ishima Y, Taguchi K, Watanabe H, Maruyama T, Otagiri M. Human serum albumin-thioredoxin fusion protein with long blood retention property is effective in suppressing lung injury. J Control Release. 2011 Sep 5;154(2):189-95.
  6. 6.Tanaka M, Tokunaga K, Maruyama T, Otagiri M, Tominaga Y, Itoh K, Matsushita K, Komaba H, Fukagawa M Parathyroidectomy markedly reduces oxidative stress in a patient with primary hyperparathyroidism. Ther Apher Dial. 2011 Jun;15 Suppl 1:38-41. doi:
  7. 7.Watanabe H, Miyamoto Y, Otagiri M, Maruyama T. Update on the pharmacokinetics and redox properties of protein-bound uremic toxins. J Pharm Sci. 2011 Sep;100(9):3682-95
  8. 8.Kugimiya T, Jono H, Saito S, Maruyama T, Kadowaki D, Misumi Y, Hoshii Y, Tasaki M, Su Y, Ueda M, Obayashi K, Shono M, Otagiri M, Ando Y. Loss of functional albumin triggers acceleration of transthyretin amyloid fibril formation in familial amyloidotic polyneuropathy. Lab Invest. 2011 Aug;91(8):1219-28
  9. 9.Kaneko K, Chuang VT, Minomo A, Yamasaki K, Bhagavan NV, Maruyama T, Otagiri M. Histidine146 of human serum albumin plays a prominent role at the interface of subdomains IA and IIA in allosteric ligand binding. IUBMB Life. 2011 Apr;63(4):277-85
  10. 10.Anraku M, Takeuchi K, Watanabe H, Kadowaki D, Kitamura K, Tomita K, Kuniyasu A, Suenaga A, Maruyama T, Otagiri M. Quantitative analysis of cysteine-34 on the anitioxidative properties of human serum albumin in hemodialysis patients. J Pharm Sci. 2011 Sep;100(9):3968-76
  11. 11.Taguchi K, Maruyama T, Otagiri M. Pharmacokinetic properties of hemoglobin vesicles as a substitute for red blood cells. Drug Metab Rev. 2011 Aug;43(3):362-73
  12. 12.Tanaka M, Tokunaga K, Komaba H, Itoh K, Matsushita K, Watanabe H, Kadowaki D, Maruyama T, Otagiri M, Fukagawa M. Vitamin d receptor activator reduces oxidative stress in hemodialysis patients with secondary hyperparathyroidism. Ther Apher Dial. 2011 Apr;15(2):161-8.
  13. 13.Miyamoto Y, Watanabe H, Otagiri M, Maruyama T. New insight into the redox properties of uremic solute indoxyl sulfate as a pro- and anti-oxidant. Ther Apher Dial. 2011 Apr;15(2):129-31. Review
  14. 14.Mera K, Nagai R, Takeo K, Izumi M, Maruyama T, Otagiri M. An autoantibody against N(ε)-(carboxyethyl)lysine (CEL): Possible involvement in the removal of CEL-modified proteins by macrophages. Biochem Biophys Res Commun. 2011 Apr 8;407(2):420-5.
  15. 15.Nishi K, Ono T, Nakamura T, Fukunaga N, Izumi M, Watanabe H, Suenaga A, Maruyama T, Yamagata Y, Curry S,Otagiri M. Structural Insights into Differences in Drug-binding Selectivity between Two Forms of Human {alpha}1-Acid Glycoprotein Genetic Variants, the A and F1*S Forms. J Biol Chem. 2011 Apr 22;286(16):14427-34.
  16. 16.Miyamoto Y, Watanabe H, Noguchi T, Kotani S, Nakajima M, Kadowaki D, Otagiri M, Maruyama T.Organic anion transporters play an important role in the uptake of p-cresyl sulfate, a uremic toxin, in the kidney.　Nephrol Dial Transplant. 2011 (in press)
  17. 17.Taguchi K, Ogaki S, Watanabe H, Kadowaki D, Sakai H, Kobayashi K, Horinouchi H, Maruyama T, Otagiri M. Fluid Resuscitation with Hemoglobin Vesicles Prevents Escherichia coli Growth via Complement Activation in a Hemorrhagic Shock Rat Model. J Pharmacol Exp Ther. 2011 Apr;337(1):201-8.